These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9490499)

  • 1. [The response of peripheral blood lymphocytes from lung cancer patients to in-vitro treatment with recombinant interleukin-2].
    Pogodina ON; Karaseva NA; Ivanov VA
    Tsitologiia; 1997; 39(7):582-9. PubMed ID: 9490499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human recombinant interleukin 2 on in vitro tumor cytotoxicity in dogs.
    Raskin RE; Holcomb CS; Maxwell AK
    Am J Vet Res; 1991 Dec; 52(12):2029-32. PubMed ID: 1789517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients].
    Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh
    Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
    Konjević G; Spuzić I
    Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional activity of the natural killers and macrophages in patients with breast tumors].
    Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
    Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the cytostatic and cytotoxic activities of the peripheral blood lymphocytes in the surgical treatment of lung cancer patients].
    Polushina OA; Lian NV; Bogdashin IV
    Vopr Onkol; 1992; 38(2):173-7. PubMed ID: 1300702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The count of the large granule-containing lymphocytes of the peripheral blood and the natural killer activity in patients with malignant tumors].
    Kindzel'skiĭ LP; Zlochevskaia LL; Tsyganok TV; Shabaeva MM; Zhukova MM; Rudaia OI
    Vrach Delo; 1990 Aug; (8):31-2. PubMed ID: 2256279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
    Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
    Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of recombinant interleukin 2 on peripheral blood lymphocytes in vitro. IV. Cytotoxicity of lymphocytes in patients with malignant tumors].
    Jíra M; Strejcek J; Faltýn J; Chodounský Z; Suchomelová M; Tomásová M; Zábojová E; Procházka M
    Cas Lek Cesk; 1988 Nov; 127(46):1422-4. PubMed ID: 3264757
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer].
    Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of cytokine-induced killer cells against human lung cancer.
    Kim HM; Lim J; Park SK; Kang JS; Lee K; Lee CW; Lee KH; Yun MJ; Yang KH; Han G; Kwon SW; Kim Y; Han SB
    Int Immunopharmacol; 2007 Dec; 7(13):1802-7. PubMed ID: 17996691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells.
    Baral E; Nagy E; Krepart GV; Lotocki RJ; Unruh HW; Berczi I
    Anticancer Res; 2000; 20(3B):2027-31. PubMed ID: 10928146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M; Jewett A
    Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.